Genetic Signature May Help Tailor Treatment for Meningioma - Cancer Currents Blog

National Cancer Institute sent this bulletin at 12/21/2023 10:34 AM EST

Having trouble viewing this email? View it as a Web page.

Genetic Signature May Help Tailor Treatment for Meningioma
12/21/2023
	The activity of 34 genes can accurately predict the aggressiveness of meningiomas, a new study shows. This gene expression signature may help oncologists select the best treatments for people with this common type of brain cancer than they can with current methods.

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.